FDA — authorised 17 November 1973
- Marketing authorisation holder: GE HEALTHCARE
- Status: approved
FDA authorised Metrizoate on 17 November 1973
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 17 November 1973.
GE HEALTHCARE holds the US marketing authorisation.